Drug Database
Back to search

Belgium· BE-AMP-SAM509457-00

Parsabiv 2.5 mg

A etelcalcetide product containing etelcalcetide hydrochloride, registered in Belgium by Amgen Europe. The same ATC class is registered in 14 of our 19 countries.

ATC H05BX04

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedParsabiv 2.5 mgATCH05BX04REGISTER NO.BE-AMP-SAM509457-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about etelcalcetide hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Etelcalcetide is registered in 14 of 19 countries.

Countries holding a registration under ATC H05BX04 (etelcalcetide), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 10 of them publish a price we can compare per daily dose
Search etelcalcetide products by name

Etelcalcetide · ATC H05BX04

14 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Etelcalcetide Hydrochloride
Manufacturer
Amgen Europe
Country
Belgium (BE)
ATC code
H05BX04
ATC class
Etelcalcetide
Defined daily dose
2.1 mg, P
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    7722622
  • be_apb
    3738978

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

20 interactions on record for etelcalcetide.

Graded by severity as the source publishes them — 19 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check etelcalcetide against other medicinesHow interaction checks work

Etelcalcetide · interactions on record

20 records

  • 19 severe
  • 1 moderate

Most severe, free to view

  • FurosemideC03CA01severe
  • BumetanideC03CA02severe
  • TorasemideC03CA04severe
  • Etacrynic acidC03CC01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Etelcalcetide in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All etelcalcetide products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Iceland · Parsabiv
  • Norway · Parsabiv

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e77699a2-d2c5-4162-af22-e3bc154250aa
GET /v1/drugs/e77699a2-d2c5-4162-af22-e3bc154250aa?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Parsabiv 2.5 mg",
  "name_fr": "Parsabiv 2.5 mg",
  "name_nl": "Parsabiv 2.5 mg",
  "amp_code": "SAM509457-00",
  "strengths": [
    "5.0000"
  ],
  "pack_count": 4,
  "substances": [
    "Etelcalcetide Hydrochloride",
    "Etelcalcetide",
    "Sodium Chloride",
    "Sodium Hydroxide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Etelcalcetide",
  "authorisation_numbers": [
    "EU/1/16/1142/002",
    "EU/1/16/1142/001",
    "EU/1/16/1142/004",
    "EU/1/16/1142/003"
  ]
}
API referenceMCP serverPlans

See everything about etelcalcetide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console